Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation

Posaconazole (PCZ) is frequently used for prophylaxis against invasive fungal infections (IFI) in patients undergoing induction chemotherapy for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Posaconazole is commercially available as an oral suspension (PCZ-susp) and as a delayed-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Belling, Morgan, Kanate, Abraham S., Shillingburg, Alexandra, Lu, Xiaoxiao, Wen, Sijin, Shah, Nilay, Craig, Michael, Cumpston, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485328/
https://www.ncbi.nlm.nih.gov/pubmed/28695013
http://dx.doi.org/10.1155/2017/3460892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485328/
https://www.ncbi.nlm.nih.gov/pubmed/28695013
http://dx.doi.org/10.1155/2017/3460892

Ejemplares similares